BeStock  
Stocks › Biotechnology › NUVB

Nuvation Bio NUVB

US equityMarket cap rank #2962Biotechnology
$3.80 −$0.01 (-0.26%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $3.80 0.00%
Open$3.77
Prev close$3.81
Day range$3.72 – $3.91
Volume6.85M
Market cap$1.34B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±7.9%last 7 reports
Closed higher2 of 729% of the time
Best reaction+9.5%
Worst reaction-25.3%

Stock move on the day after each report

-6.2%2022/Q1+2.9%2025/Q1-0.4%2025/Q2-6.6%2025/Q3-25.3%2025/Q4+9.5%2026/Q1-4.1%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q26 Aug 2026Pre Market±23.6%-4.08%Within range
2026/Q14 May 2026After Market±18.1%+9.52%Within range
2025/Q42 Mar 2026After Market±30.4%-25.34%Within range
2025/Q33 Nov 2025After Market±24.2%-6.58%Within range
2025/Q27 Aug 2025Pre Market±18.7%-0.43%Within range
2025/Q17 May 2025After Market±24.5%+2.94%Within range
2022/Q19 May 2022None–-6.21%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$44.95M+242.6% YoY
Operating profit-$42.21M+25.2% YoY
Net profit-$41.90M+24.9% YoY
Diluted EPS-$0.12+25.0% YoY
Free cash flow-$40.15M+34.1% YoY
Operating cash flow-$38.56M

Revenue, last 8 quarters

$5.7MDec '24$3.1MMar '25$4.8MJun '25$13.1MSep '25$41.9MDec '25$83.2MMar '26$31.7MJun '26$45.0MSep '26

Net profit, last 8 quarters

$-49.4MDec '24$-53.2MMar '25$-59.0MJun '25$-55.8MSep '25$-36.6MDec '25$5.4MMar '26$-62.8MJun '26$-41.9MSep '26

Profitability & balance sheet

Gross margin85.8%
Operating margin-61.2%
Net margin-67.4%
Return on equity-49.1%
Return on assets-19.7%
Return on invested capital-28.7%
Current ratio7.45
Liabilities / assets70.7%
Cash & investments$663.37M
Total debt$299.66M
Net cash (debt)$363.72M

Discussion

No comments yet — be the first to weigh in on NUVB.

Sign in to join the discussion.

Scroll to Top